C4 Therapeutics, Inc. · NASDAQ:CCCC

Wasatch Advisors LP reported a 6.80% stake in C4 Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 13, 2025

Wasatch Advisors LP reported a 6.80% stake in C4 Therapeutics, Inc., 4,852,741 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).

Stake
6.80%
Shares
4,852,741
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Wasatch Advisors LP6.80%4,852,741

Source

View original at SEC

Related